Identification Generic Name (1s,3r,4r,6s)-1,3,4,6-Tetrapkisphosphate DrugBank Accession Number DB04300 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 Download  MOL SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (1s,3r,4r,6s)-1,3,4,6-Tetrapkisphosphate (DB04300) ×  Close Weight Average: 500.0755  Monoisotopic: 499.928709756  Chemical Formula C 6 H 16 O 18 P 4 Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Not Available Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as inositol phosphates. These are compounds containing a phosphate group attached to an inositol (or cyclohexanehexol) moiety. Kingdom Organic compounds Super Class Organic oxygen compounds Class Organooxygen compounds Sub Class Alcohols and polyols Direct Parent Inositol phosphates Alternative Parents Monoalkyl phosphates  /  Cyclohexanols  /  Organic oxides  /  Hydrocarbon derivatives Substituents Aliphatic homomonocyclic compound  /  Alkyl phosphate  /  Cyclohexanol  /  Hydrocarbon derivative  /  Inositol phosphate  /  Monoalkyl phosphate  /  Organic oxide  /  Organic phosphoric acid derivative  /  Phosphoric acid ester  /  Secondary alcohol Molecular Framework Aliphatic homomonocyclic compounds External Descriptors myo-inositol tetrakisphosphate ( CHEBI:16155 )  Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key ZAWIXNGTTZTBKV-JMVOWJSSSA-N InChI InChI=1S/C6H16O18P4/c7-1-3(21-25(9,10)11)5(23-27(15,16)17)2(8)6(24-28(18,19)20)4(1)22-26(12,13)14/h1-8H,(H2,9,10,11)(H2,12,13,14)(H2,15,16,17)(H2,18,19,20)/t1-,2+,3-,4+,5-,6+ IUPAC Name {[(1R,2s,3S,4S,5r,6R)-2,5-dihydroxy-3,4,6-tris(phosphonooxy)cyclohexyl]oxy}phosphonic acid SMILES O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@@H](O)[C@@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O References General References Not Available External Links Human Metabolome Database HMDB0001187 KEGG Compound C04477 PubChem Compound 121969 PubChem Substance 46506539 ChemSpider 17216082 ChEBI 16155 ZINC ZINC000071789370 PDBe Ligand I4P PDB Entries 1z2o Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 11.5 mg/mL ALOGPS logP -0.45 ALOGPS logP -4.3 Chemaxon logS -1.6 ALOGPS pKa (Strongest Acidic) 0.35 Chemaxon Physiological Charge -8 Chemaxon Hydrogen Acceptor Count 14 Chemaxon Hydrogen Donor Count 10 Chemaxon Polar Surface Area 307.5 Å 2 Chemaxon Rotatable Bond Count 8 Chemaxon Refractivity 79.27 m 3 ·mol -1 Chemaxon Polarizability 33.68 Å 3 Chemaxon Number of Rings 1 Chemaxon Bioavailability 0 Chemaxon Rule of Five No Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption - 0.5918 Blood Brain Barrier + 0.9414 Caco-2 permeable - 0.6991 P-glycoprotein substrate Non-substrate 0.7889 P-glycoprotein inhibitor I Non-inhibitor 0.8014 P-glycoprotein inhibitor II Non-inhibitor 0.9703 Renal organic cation transporter Non-inhibitor 0.9224 CYP450 2C9 substrate Non-substrate 0.823 CYP450 2D6 substrate Non-substrate 0.8507 CYP450 3A4 substrate Non-substrate 0.6466 CYP450 1A2 substrate Non-inhibitor 0.94 CYP450 2C9 inhibitor Non-inhibitor 0.92 CYP450 2D6 inhibitor Non-inhibitor 0.9294 CYP450 2C19 inhibitor Non-inhibitor 0.8948 CYP450 3A4 inhibitor Non-inhibitor 0.9813 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.9738 Ames test Non AMES toxic 0.8837 Carcinogenicity Non-carcinogens 0.6979 Biodegradation Not ready biodegradable 0.8459 Rat acute toxicity 2.2264 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9125 hERG inhibition (predictor II) Non-inhibitor 0.9425    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS Not Available Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52 